ArticleJapanese journal of clinical oncology2024

Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.

Yao Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.